Savara Inc Public Float
Savara Inc (SVRA) had Public Float of $544.46 million as of 2025-06-30, per its 10-K filed 2026-03-13.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-13
- 2025-06-30: Entity Public Float $544.46M.
- 2024-06-30: Entity Public Float $544.46M.
- 2023-06-30: Entity Public Float $410.50M.
- 2022-06-30: Entity Public Float $159.29M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $544.46M 10-K · filed 2026-03-13 |
| 2024-06-30 | $544.46M 10-K/A · filed 2025-04-25 |
| 2023-06-30 | $410.50M 10-K · filed 2024-03-07 |
| 2022-06-30 | $159.29M 10-K · filed 2023-03-30 |
| 2021-06-30 | $179.51M 10-K · filed 2022-03-30 |
| 2020-06-30 | $116.50M 10-K · filed 2021-03-10 |
| 2019-06-28 | $78.00M 10-K · filed 2020-03-12 |
| 2018-06-29 | $146.67M 10-K · filed 2019-03-13 |
| 2017-06-30 | $135.69M 10-K · filed 2018-03-14 |
| 2016-06-30 | $96.10M 10-K · filed 2017-03-06 |
| 2015-06-30 | $77.00M 10-K · filed 2016-03-14 |
| 2014-06-30 | $74.00M 10-K · filed 2015-03-24 |
| 2013-06-28 | $44.00M 10-K · filed 2014-03-26 |
| 2012-06-29 | $24.00M 10-K · filed 2013-03-19 |
| 2011-06-30 | $77.90M 10-K · filed 2012-03-08 |
| 2010-06-30 | $24.00M 10-Q · filed 2011-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |